{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:26:57Z","timestamp":1793849217034,"version":"4.6.1"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"DOI":"10.1186\/s13054-026-06352-8","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T08:06:41Z","timestamp":1790582801000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lower limits of CRRT dose-intensity: what does the evidence support?"],"prefix":"10.1186","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1506-4253","authenticated-orcid":false,"given":"Nuttha","family":"Lumlertgul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"Bagshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"6352_CR1","doi-asserted-by":"crossref","unstructured":"Lumlertgul N, Kusirisin P, Kung JY, Duquette D, Fujii T, Zarbock A, Wald R, Bagshaw SM. Lower versus standard dose-intensity continuous renal replacement therapy: a systematic review and meta-analysis. Crit Care. 2026;30(1).","DOI":"10.1186\/s13054-026-05987-x"},{"key":"6352_CR2","doi-asserted-by":"publisher","unstructured":"Mei S, Yi H, Han Y, Dong B, Liu Y, Gong X. Estimate selection determines the apparent mortality threshold at 13 mL\/kg\/h. Crit Care. 2026;30:473. https:\/\/doi.org\/10.1186\/s13054-026-06328-8.","DOI":"10.1186\/s13054-026-06328-8"},{"issue":"2","key":"6352_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1053\/j.ajkd.2024.01.526","volume":"84","author":"K Okamoto","year":"2024","unstructured":"Okamoto K, Fukushima H, Kawaguchi M, Tsuruya K. Low-Dose Continuous Kidney Replacement Therapy and Mortality in Critically Ill Patients With Acute Kidney Injury: A Retrospective Cohort Study. Am J Kidney Dis. 2024;84(2):145\u2013e153141.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"6352_CR4","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/SHK.0000000000002435","volume":"63","author":"MLM Faria","year":"2025","unstructured":"Faria MLM, Lib\u00f3rio AB. Continuous kidney replacement therapy dosage and mortality in critically ill patients: a retrospective cohort study using marginal structural model. Shock. 2025;63(2):202\u20139.","journal-title":"Shock"},{"issue":"1","key":"6352_CR5","doi-asserted-by":"publisher","first-page":"e112086","DOI":"10.1136\/bmjopen-2025-112086","volume":"16","author":"N Lumlertgul","year":"2026","unstructured":"Lumlertgul N, Kusirisin P, Kung JY, Duquette D, Fujii T, Zarbock A, Wald R, Bagshaw SM. Lower versus standard dose-intensity continuous renal replacement therapy: a protocol for a systematic review and meta-analysis. BMJ Open. 2026;16(1):e112086.","journal-title":"BMJ Open"},{"key":"6352_CR6","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"6352_CR7","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane handbook for systematic reviews of interventions version 6.5. Cochrane. 2024."},{"key":"6352_CR8","doi-asserted-by":"crossref","unstructured":"Tran BV, Huynh PY, Hoang BB, Kao CC, Tran TT, Kim S. Association between continuous kidney replacement therapy intensity and mortality in critically ill patients: a retrospective cohort study from the MIMIC-IV database. Blood Purif 2026:1\u201313.","DOI":"10.1159\/000552963"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-06352-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-026-06352-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-06352-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:03:29Z","timestamp":1793847809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-026-06352-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":8,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6352"],"URL":"https:\/\/doi.org\/10.1186\/s13054-026-06352-8","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"15 September 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This article uses only aggregate data reported in previously published studies and does not involve human participants, individual-level human data, human tissue, or animals.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SMB has received fees for scientific advisory from BioPorto, CalciMedica, Novartis, and Vantive; and has received grant support from Vantive. NL has received speaker fees from Vantive.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"501"}}